A

Ai3Bio

Health

Ai3Bio has launched with a $48 million Series A funding round. The company aims to reset the immune system, suggesting a focus on novel therapeutic approaches for immune-related diseases.

Total raised
Undisclosed
tracked to date
Latest round
Series A
Sep 30, 2026

Is this your company?

Claim this profile to get matched with investors who fund Health startups.

Claim this profile →

Funding history

  1. 1
    $48M Series ASeries ASep 30, 2026
    Announcement ↗

Ai3Bio in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile